Username:
Password:
Log me on automatically each visit
 
 
It is currently Sat Nov 26, 2022 4:06 am
Post a new topic Post a reply  [ 1 post ]   
Author Message
 Post subject: DHEA for prostate cancer
PostPosted: Mon Jan 11, 2021 11:51 am 
Site Admin
User avatar

Joined: Wed May 27, 2015 10:20 am
Posts: 503
Beneficial effects and side effects of DHEA: true anti-aging and age-promoting effects, as well as anti-cancer and cancer-promoting effects of DHEA evaluated from the effects on the normal and cancer cell telomeres and other parameters.

Omura Y1


Quote:
Abstract

The author evaluated the effects of DHEA (Dehydroepiandrosterone) on the amount of telomeres of normal cells and cancer cells and found the following: Contrary to the literature, which often recommended 25-50 mg of DHEA daily for the average adult human being, the author found that, depending on the individual, the maximum increase of normal cell telomere was obtained by a single optimal dose of 1.25-12.5 mg.

This was examined in 50 people, both males and females, between the ages of 20-80 years old. When one optimal dose was given to each individual, the average telomere amount in normal tissues, measured in Bi-Digital O-Ring Test units, often increased from anywhere between 25-300 ng to between 500-530 ng. Cancer cell telomere reduced from higher than 1100 ng to less than 1 yg (=10(-24) g) with equally significant normalization of abnormal cancer parameters (such as Integrin alpha5beta1, Oncogen C-fosAb2, Acetylcholine, etc.). Circulatory improvement and an increase in grasping force of up to 25% were also detected, along with the changing of a few white hairs to black hairs. The beneficial effects of one optimal dose of DHEA generally lasted between 1 to 4 months, though in some individuals it lasted for a much shorter period of time due to a number of negative factors such as excessive stress/work, excessive exposure to low temperatures and toxic substances, or use of common pain medicines.

On the other hand, if a patient took an excessive dose of DHEA, the amount of normal cell telomere decreased, while there was an increase in cancer cell telomere. It was found that those who took an overdose of 25-50 mg daily for more than 3 months had a high incidence of cancer of the prostate gland, breast, colon, lung, and stomach. Also, when the average normal cell telomere levels were less than 110 ng, compared with a normal value of 120-130 ng, and when DHEA in different parts of the body was also extremely low (less than 1-2 ng), one could suspect the possible presence of a malignant tumor somewhere in the body. When normal cell telomere was less than 110 ng, most individuals felt very weary with marked tiredness in the eyes, and grasping force was often reduced.


--------

Quote:
Adenocarcinoma of the Prostate Gland

I started attending Dr. Omura’s seminars and workshops for physicians and dentists in New York regularly in 2005, after my friend Don received a diagnosis of Prostate Cancer and sought an alternative to surgery or radiation. Don’s PSA had spiked to around 10 and his diagnosis was based on biopsy. Dr. Omura evaluated him using the BDORT and treated him with one (single) optimal dose of DHEA and found clothing for him that would not interfere with the treatment (maintaining optimal Telomere levels). Don’s sleep improved tremendously starting the first night, as his frequency of urination reduced from 7 times per night to once per night. He regained his strength and golf swing. His malignant tumor began to shrink on sonography, and his PSA dropped below 3 (it was 2.6 a few weeks ago). His oncologist was amazed, his urologist supportive, and his family physician felt betrayed because Don went against his recommendations. It will be 2 years since Don’s first visit to New York this December.

Dr. Omura published his findings as Clinical Case #9 (Anti-Cancer Effects of One Optimal Dose of DHEA (7 mg) on Adenocarcinoma of Prostate Gland) in the article “Beneficial Effects and Side Effects of DHEA” in Acupuncture and Electro-Therapeutics Research, The International Journal, Volume 30, Number 3/4, 2005 (ISSN 0360-1293).


------------

The Bi-Digital O-Ring Test (BDORT), characterized as a form of applied kinesiology,[2] is a patented alternative medicine diagnostic procedure in which a patient forms an 'O' with his or her fingers, and the diagnostician subjectively evaluates the patient's health according to the patient's finger strength as the diagnostician tries to pry them apart.[1][3]


BDORT was invented by Yoshiaki Omura, along with several other related alternative medicine techniques. They are featured in Omura's self-published Acupuncture & Electro-Therapeutics Research, The International Journal, of which Omura is founder and editor-in-chief, as well as in seminars presented by Omura and his colleagues.

Attachment:
bdort.png


-------------------

.
Quote:
. . beneficial effects ranging from those characterized by antiaging,
anti-osteoporosis. anti-obesity (anti-fat), anti-viral, anti-bacterial, anti-stress, anti-memory
deficiency, anti-cardiovascular disease, anti-diabetic, anti-cancer, and immune enhancing
properties, as well as the extremes of prostate and breast cancer-promoting
effects. The molecular structure of DHEA and metabolic pathways
among cholesterol, DHEA, various steroid hormones, and sex hormones are illustrated in
Figure 0. These completely contradictory reports are very confusing and disturbing for
not only patients and medical professionals but also average individuals interested in
health. In order to find out the truth, the author began to study the effects of DHEA.

First, the author noticed that most of the amounts of DHEA recommended for the
average adult in popular books ranged anywhere from 25-50 mg daily to 50-100 mg
daily, although they suggested a lesser amount for women (6, 8). Using the Bi-Digital O-Ring
Test, the optimal dose for each patient or volunteer was examined and found in
most of the subjects to be anywhere between 1.25-12.5 mg for 50 males and females
ranging from 20-80 years old. This was contrary to the widely used 25-50 mg daily dose.
Initially, when the author started using the optima! dose 2-3 times daily, the total amount
was still close to or less than the recommended daily dose. When the author examined
the effects of DHEA on normal cell telomere when one optimal dose a day was given, it
was found that in most of the individuals with reduced normal cell telomere, normal cell
telomere usually increased significantly. However, when the author gave on the same
day a 2nd dose of the same originally determined optimal dose, the normal cell telomere
significantly decreased; the telomere further decreased when an optimal dose was given a
3 time on the same day. Because of this, the author decided to study how long the
effects of one optimal dose of DHEA on the normal cell telomere would last. As a
consequence, the author found that in the majority of average adults, one dose of the
optimal amount of DHHA lasted anywhere between 1-4 months.
Not only that, but when
one optimal dose was given, cancer cell telomere and other abnormally increased cancer
parameters became close to zero.

On the other hand, when 25 mg of DHEA was given, normal cell telomere never
increased but instead decreased in every subject, although transitionally most people felt
their general condition to be improved. When one optimal dose of DHEA was given to
an individual, average normal cell telomere increased to a minimum of 500 ng and a
maximum of 530 ng in Bi-Digital 0-Ring Test units, and the abnormally increased (of
more than 1100 ng) cancer cell telomere became practically zero (1 yg= 10'^'' g, or less).
When 25 mg, which is an overdose for almost every individual (except for excessively
overweight people), was given every day, not only did the amount of normal cell
telomere not increase, but it actually went down below the original amount. Cancer cell
telomere and other abnormally increased cancer parameters also increased by giving an
overdose of DHEA, such as 25 or 50 mg. In this article, the author describes these
important relationships that can clarify previously published completely contradictory
claims of the beneficial and adverse effects of DHEA.

One of the advantages of using the Bi-Digital 0-Ring Test is not only that one can
determine whether a certain substance is beneficial or harmful, but also that one can
determine the optimal dose (if beneficial) before giving the actual substance to the
patient. Therefore, the author called this method of testing specific drug effects without
having the patient actually take the drug "Virtual Drug Testing" (See example of Testing
in clinical case U2). The author tested all of these commercially available DHEA brands
in approximately the same amounts. The results were more or less identical, in spite of
some of them having small amounts of different impurity materials other than DHEA.

Clinical Case #9:

Anti-Cancer Effects of One Optimal Dose of DHEA (7 mg) on Adenocarcinoma of
Prostate Gland


A 60 year-old Caucasian male financial adviser from North Carolina who was suffering
from frequent urination, which had recently become worse with an average of 5 to 7
times a night and every 60-90 minutes in the daytime for the past year, was brought by
his dentist. Dr. Andrew Fallow of California, to one of the author's 3 day weekend
seminars and workshops in New York City.

Recently, he went to a urologist, and PSA
was found to be 9.5 ng/ml of blood and a biopsy indicated Adenocarcinoma of left
prostate gland in November 2005. He did not wish to have surgery or radioactive needle
implantation and wanted to explore any alternative treatment and see the result; based on
that, he wanted to determine his future treatment. The previous study indicated that
without giving actual medication the author can evaluate potential drug effects very accurately by using Bi-Digital 0-Ring Test Virtual Drug Test. By doing this, the author
does not need to expose the patient to potential danger by giving an overdose of
potentially beneficial medication. The patient's average normal cell telomere in Bi-
Digital 0-Ring Test units indicated a very low value of 60 ng. Again, the previous study
indicated when the average normal cell telomcre in Bi-Digita! 0-Ring Test measurement
at the upper arm was less than 110 ng. frequently there is a cancer somewhere in the
body. Therefore, the author non-invasively screened for cancer by projecting a red
spectrum soft laser placed next to 60 ng of Integrin OjP, in the hand of the intermediary
person using indirect Bi-Digita! 0-Ring Test. The laser beam was projected in the right
hand, left hand, supra-sternal notch, between the nipples, navel, right and left inguinal
area, and on the back of the body, including the back of the right and left hands. 7th
cervical vertebrae, in the center of the spine at the back of the chest, the lumbar area,
anus, and the right and left giuteal groove. If there was identical Integrin a^^^ existing in
the area of the body where the laser beam was projected or in its vicinity, it would
produce resonance between the information carried from the laser beam on Integrin a<;P,
and its amount. When these have identical amounts, the electromagnetic resonance
would become a maximum. Empirically, when 1 or 2 0-Rings open (-1 or -2), it is
considered to be within normal limits. If 3 0-Rings open (0-Ring test -3), it is
considered to be borderline. If 4 0-Rings (-4) or more 0-Rings open, it is considered to
be cancer positive. If 6 0-Rings open (-6). it is considered to be strongly cancer-positive.
In this patient, the right arm was -4. the supra-sternal notch was -6, between the nipples
was -5, navel was -5, both right and left inguinal areas were -6.

Therefore, to localize
cancer-positive areas. X-axis and Y-axis laser beam scanning with 60 ng of Integrin a^pi
found that there was a strong cancer-positive area in the upper part of the chest which
was found to have strong resonance with a microscope slide of Adenocarcinoma of the
prostate gland. This indicated possible metastasis of prostate cancer to upper chest. At
the left lower abdomen, there was a strong cancer positive area that produced strong
resonance with Adenocarcinoma of the colon. Then, the entire left prostate gland area
was -6 and part of the right prostate gland was also -6. These prostate gland areas
produced strong resonance with a microscope slide of Adenocarcinoma of the prostate
gland.

For this patient, after an informed consent form was signed, optimal dosage of
DHEA was found to be 7 mg when the Virtual Drug Test was performed and when the
effect of DHEA (10 mg) was examined, telomere further decreased from an already
abnormally low level of 50 ng. When the patient was tested with 20 mg of DHEA,
telomere levels became less than 25 ng.

However, when the effect of one optimal dose
of DHEA (7 mg) on normal cell telomere was examined, normal cell telomere went up to
520 ng, which is the ideal response, since all of the author's previous study indicated
when the optimal dose of DHEA is given (usually 1.25 mg-12.5 mg depending upon the
individual), normal cell telomere always increases to anywhere between a minimum of
500 ng and a maximum of 530 ng. In the cancer-positive area, the local amount of
DHEA was always less than I or 2 ng and TXB2 was an abnormally high 300 ng, which
indicated the presence of moderate circulatory disturbance in the cancer tissue.
Acetylcholine was 5 ng, which is markedly diminished compared with normal tissue of at
least a few hundred fxg. and average cancer tissue telomere was 1300 ng in both prostate cancer positive area and Adenocarcinoma of colon positive area. Integrin asPi was 350 ng, which was very high and a characteristic common finding in the cancer tissue.

Before the author gave an optimal dose of DHEA, the author also noticed that by visual
inspection, the hair on the patient's head corresponding to the organ representation area
of the prostate gland was much thinner than the rest of the head. Therefore, the author
marked an organ representation area of the prostate gland on the right and left sides of
the top of the head. On the right side of the top of the head, located slightly posterior
from the center of the head corresponding to the left prostate gland representation area as
shown in round-shaped area, there was a strong positive Bi-Digital 0-Ring Test
resonance with microscope slide of Adenocarcinoma of prostate gland. On the other
hand, on the left side of the top of the head corresponding to the right prostate gland in a
rectangular shape, a small part of the area had a Adenocarcinoma of prostate-positive
response, which indicated either it coexisted at the same time as left prostate cancer or
that the left prostate cancer might have spread to part of the right prostate gland. (See
figures 4A-4C).

Similarly, the author examined the prostate gland representation area on the sole of the
foot. In the left foot, the entire prostate gland representation area in the lateral side of the
left heel had a strong positive resonance with Adenocarcinoma of the prostate gland.
When the right foot prostate gland representation area was mapped, a small part also
produced a strong resonance with prostate cancer, which also indicated that there may be
some metastasis to the right prostate gland or coexisted simultaneously as left prostate
cancer.

In the palm of the patient's left hand, a triangular shape corresponding to the prostate
gland had a strong Adenocarcinoma of the prostate gland response. On the right hand
palm, part of the triangular-shaped prostate gland representation area also showed
Adenocarcinoma of the prostate gland response.

When one optimal dose of pure DHEA (7 mg) for this patient was given orally, as the
Virtual Drug Test predicted, average normal cell telomere increased from 45 ng to 520
ng. Within 10 minutes after oral intake of one optimal dose of DHEA (7 mg) with water,
Integrin aspi and cancer cell telomere reduced from 1300 ng to less than 1 yg (=10" g),
and TXB2 became reduced from 300 ng to much less than 1 ng. Acetylcholine went up
from 5 ag (=10"'* g) to 40 ^g as can be seen in the figures 4a to 4c. When very high
cancer cell telomere of 1200 ng is reduced to 1 yg or less, the cancer cell can no longer
divide.

The next morning, when the patient came back, he was very happy to report that bis
frequent urination markedly reduced; in fact for the first time in months he only needed
to go to the bathroom once during the night. Also, similarly, daytime urination
frequency reduced markedly. Forty-eight hours later, for the first time, he did not wake
up even once during the night to use the bathroom. Daytime urination frequency reduced
to normal levels, he felt much more vigorous, and it was easier to think and concentrate,
because for the 1st time he was able to sleep without interruptions.

During the 3-day weekend seminar and workshop in New York, after initial treatment
with one optimal dose of DHEA of 7 mg, without giving any additional medication, the measurement was repeated daily. The effect remained the same on Sunday afternoon,
two days after treatment. In order to prevent possible decrease in normal cell telomere,
the patient was supposed to fax the author right and left handwriting samples as well as
right and left foot writing samples, from which it was possible to estimate the amount of
normal cell telomere and DHHA, as well as any abnormal increase in Integrin ajp, or
Oncogen C-fos Abj. Six days after the first treatment, he has been sending handwriting
samples every 3 days which indicate both normal cell telomere and DHEA remained the
same after the first treatment; meanwhile, the author requested that he carry out a
repeated PSA blood test periodically by the same clinical laboratory. Ten days after
initial treatment with one optimal dose of DHEA (7 mg), the standard blood PSA was
examined and the value of this laboratory test was reported to be 4.7 ng/ml, which was
still slightly higher than the normal range of 0-4 ng/ml. Compared with his initial PSA
testing before the author gave one optimal dose of DHEA (7 mg) treatment, there was a
significant reduction from 9.5 ng/ml to 4.7 ng/ml 10 days after intake of one optimal
dose of DHEA. Twenty days after the first optimal dose of DHEA, the patient's PSA
was repeated and it was further reduced to 3.4 ng/ml. All of these improvements were
obtained by only giving one optimal dose of DHEA.


https://www.google.com/url?sa=t&rct=j&q ... cF2JsR9ODr


You do not have the required permissions to view the files attached to this post.

Top
OfflineProfileReply with quote
 
Display posts from previous:  Sort by  
Post a new topic Post a reply  [ 1 post ] 
 

Who is online

Users browsing this forum: No registered users and 1 guest

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot post attachments in this forum
 
Search for:
Jump to:  
cron